share_log

Honda Prize 2024 Awarded to Dr. James G. Fujimoto of U.S.

Honda Prize 2024 Awarded to Dr. James G. Fujimoto of U.S.

2024年本田獎授予美國的James G. Fujimoto博士。
PR Newswire ·  09/30 15:00

- For Contributing to Invention and Development of Optical Coherence Tomography -

-爲光學相干斷層掃描的發明和開發做出貢獻-

TOKYO, Sept. 30, 2024 /PRNewswire/ -- The Honda Foundation is a public interest incorporated foundation established by Soichiro Honda and his younger brother Benjiro, and is currently led by President Hiroto Ishida. The foundation established the Honda Prize in 1980 as Japan's first international award that acknowledges achievements contributing to "the creation of a truly humane civilization."

東京,2024年9月30日 /PRNewswire/ — 本田基金會是由本田宗一郎和他的弟弟本次郎創立的公益基金會,目前由總裁石田宏人領導。該基金會於1980年設立了本田獎,這是日本第一個國際獎項,旨在表彰爲 「創造真正的人道文明」 做出貢獻的成就。

In 2024, the 45th Honda Prize will be awarded to Dr. James G. Fujimoto, Elihu Thomson Professor of Electrical Engineering at the Research Laboratory of Electronics, Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology (MIT), the U.S.A., for his research group's development of optical coherence tomography (OCT). The prize also acknowledges his contribution to the commercialization and clinical translation of OCT in ophthalmology, cardiology, and biomedical research.

2024年,第45屆本田獎將頒發給美國麻省理工學院(MIT)電氣工程與計算機科學系電子研究實驗室電氣工程學教授詹姆斯·藤本博士,以表彰其研究小組對光學相干斷層掃描(OCT)的開發。該獎項還表彰了他對眼科、心臟病學和生物醫學研究中oCt的商業化和臨床翻譯的貢獻。

Image1:

圖片 1:

OCT is a new imaging modality which is analogous to ultrasound, except that it measures the echo time delay and magnitude of backscattered light instead of sound. OCT enables real-time, microscopic resolution imaging of a subsurface structure in biological tissues and materials. It has applications in multiple medical specialties as well as fundamental research and manufacturing. OCT can be combined with fiber optic catheters, endoscopes, and laparoscopes to enable imaging inside the body. It enables "optical biopsy," imaging pathology in real time, without the need to remove specimens as in conventional excisional biopsy.

oCT 是一種新的成像模式,與超聲波相似,不同之處在於它測量的是回波延遲時間和背向散射光的幅度,而不是聲音。OcT 支持對生物組織和材料中的地下結構進行實時、微觀分辨率的成像。它適用於多個醫學專業以及基礎研究和製造。oCT 可以與光纖導管、內窺鏡和腹腔鏡結合使用,以實現體內成像。它可以實現 「光學活檢」,即實時成像病理學,無需像傳統的切除活檢那樣去除標本。

The development of OCT is an example of the power of multidisciplinary collaborative research teams which span fundamental research, engineering, clinical medicine, and industry. In the late 1980s, such a multidisciplinary project was relatively uncommon, and Dr. Fujimoto's team demonstrated a pioneering approach to joint medical-engineering research.

oCT 的發展是跨基礎研究、工程、臨床醫學和工業領域的多學科合作研究團隊力量的一個例子。在20世紀80年代後期,這樣的多學科項目相對罕見,藤本博士的團隊展示了一種開創性的聯合醫學工程研究方法。

Dr. Fujimoto's team first aimed to apply OCT in ophthalmology. OCT was invented by David Huang, an MD, PhD student in Fujimoto's research group, working in close collaboration with Eric Swanson, an expert on satellite optical communication, and Drs. Carmen Puliafito and Joel Schuman, retina and glaucoma specialists. OCT has become a standard of care in ophthalmology with 20 to 30 million procedures performed worldwide every year. It facilitates early detection of diseases such as age-related macular degeneration, diabetic retinopathy, and glaucoma, enabling patients to be treated before irreversible loss of vision occurs.

藤本博士的團隊最初的目標是將oCT應用於眼科。OcT是由藤本研究組的醫學博士、博士生黃大衛與衛星光通信專家埃裏克·斯旺森以及視網膜和青光眼專家卡門·普利亞菲託博士和喬爾·舒曼博士密切合作發明的。oCt已成爲眼科護理的標準,全球每年進行20至3000萬例手術。它有助於及早發現與年齡相關的黃斑變性、糖尿病視網膜病變和青光眼等疾病,使患者能夠在不可逆轉的視力喪失發生之前接受治療。

Intravascular OCT was pioneered by visiting scientist Mark Brezinski, an MD, PhD cardiologist. Startup companies led by Swanson combined with industry investment played a key role in commercializing OCT in ophthalmology as well as cardiology. Today there is an international research community with over 100 academic research groups and companies developing OCT technology and clinical applications.

血管內OcT是由訪問科學家、醫學博士、心臟病專家馬克·佈雷津斯基率先提出的。由斯旺森領導的初創公司與行業投資相結合,在眼科和心臟病學的oCt商業化中發揮了關鍵作用。如今,有一個國際研究社區,由100多個學術研究團體和公司組成,他們正在開發oCT技術和臨床應用。

Image2:

圖片 2:

OCT can be used to guide disease treatment, improving outcomes and saving health care costs. In the future, OCT of the eye may be used in optometrists' shops, drug stores, and primary care doctors' offices to screen for diabetes, neurological and other systemic diseases. In the field of cardiology, intravascular OCT is emerging as a valuable technique for guiding treatment of myocardial infarction. Clinical studies have shown intravascular OCT treatment guidance can reduce rates of major adverse cardiac events.

oCt 可用於指導疾病治療、改善預後和節省醫療保健成本。將來,眼部oCt可以用於驗光師商店、藥店和初級保健醫生辦公室來篩查糖尿病、神經系統和其他全身性疾病。在心臟病學領域,血管內oCT正在成爲指導心肌梗塞治療的寶貴技術。臨床研究表明,血管內oCT治療指導可以降低重大心臟不良事件的發生率。

Over the years, the Honda Foundation has been promoting "ecotechnology*" as its mission. Dr. Fujimoto, who led the OCT research team, is the only researcher who consistently contributed to the development and the dissemination of OCT is fully in accord with the mission and worthy of the highest recognition. Therefore, the 45th Honda Prize will be awarded to Dr. Fujimoto.

多年來,本田基金會一直在推廣 「生態技術*」 作爲其使命。領導OcT研究團隊的藤本博士是唯一一位持續爲oCt的開發和傳播做出貢獻的研究人員,這完全符合使命,值得最高的認可。因此,第45屆本田獎將頒發給藤本博士。

An award ceremony will be held at the Imperial Hotel in Tokyo, Japan, on November 18, 2024. In addition to a prize medal and a diploma, the laureate will be awarded 10 million yen.

頒獎典禮將於2024年11月18日在日本東京帝國酒店舉行。除了獎牌和文憑外,獲獎者還將獲得1000萬日元的獎勵。

*Ecotechnology: Human-friendly philosophy founded on science and technology. It is designed to harmonize the natural and human environments, and find resolutions to social issues, adopting a methodology that implies something more than just "being friendly to the Earth," which is the meaning usually associated with the word "ecology."

*生態技術:建立在科學和技術基礎上的人性化理念。它旨在協調自然和人類環境,尋找社會問題的解決方案,所採用的方法不僅僅是 「對地球友好」,而後者通常與 「生態」 一詞相關的含義。

For more information, please visit:

欲了解更多信息,請訪問:

Official website:

官方網站:

SOURCE Honda Foundation

來源:本田基金會

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

想在 PRNEWSWIRE.COM 上刊登貴公司的新聞嗎?

440k+
440k+

Newsrooms &
新聞編輯室和

Influencers
有影響力的人
9k+
9k+

Digital Media
數字媒體

Outlets
網點
270k+
270k+

Journalists
記者

Opted In
選擇加入
GET STARTED
開始吧

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論